Re: What I learned - some quotes from the presentation
in response to
by
posted on
Jun 10, 2020 01:08PM
"this adds to our ability to finance a deal related development program" (1:07)
"the following details and strategies should put the stock back into a more realistic value as it was about a year ago" (3:37 ish)
"eligability of rolling review and priority reviews" (10:12) "it went exceptionally well" (June 02 meeting) "we are following up on this meeting's advancements and recommendations as we speak".."and upon written confirmation from the FDA we will gladly inform the market AND our ongoing potential pharma co-development partners of the content of the full plans of our BETonMACE 2 registration trial"
" as a final pahse 3 registration trial will be expensive, we have decided to partner with a major pharmaceutical group at this development and commercialization point. The pharma will be responsible for funding the trial and operations. Discussions are going very well, and upon completion the future of Resverlogix will be very solid"....."until such time (that - added by me) we can confirm a partnership we will continue to fund the company internally and through whatever other methods may become available to us"